| Product Category | Examples | Composition | Mechanism | Best Indication |
|---|---|---|---|---|
| Dehydrated Human Amnion/Chorion (dHACM) | EpiFix, Affinity, AmnioBand | Dried placental membrane; growth factors (EGF, PDGF, bFGF, TGF-β); ECM | Releases growth factors; modulates inflammation; recruits stem cells | Diabetic foot ulcers; venous leg ulcers; chronic non-healing wounds |
| Cryopreserved Placental Allograft | Grafix, Stravix, Interfyl | Live/preserved cells + ECM; viable fibroblasts and epithelial cells in some products | Active cell signaling; continuous growth factor release; angiogenesis | Deep chronic ulcers; wounds needing cellular component for healing |
| Amniotic Fluid Concentrate | NovaBay, BioDFence | Concentrated amniotic fluid; hyaluronic acid; cytokines | Anti-inflammatory; antimicrobial; ECM signaling | Superficial chronic wounds; surgical closure support |
| Collagen Matrix (non-placental) | Promogran, OASIS, Dermagraft | Bovine or porcine collagen ± ORC (oxidized regenerated cellulose) | Binds MMPs; scaffolds new ECM; promotes fibroblast migration | Venous ulcers; partial-thickness wounds; MMP-elevated chronic wounds |
| Skin Substitutes (bilayer) | Apligraf, OrCel | Bilayer living skin equivalent (dermal fibroblasts + epidermal keratinocytes) | Provides dermal and epidermal components; continuous cytokine release | Diabetic neuropathic ulcers; venous ulcers; surgical coverage |
| Wound Type | First-Line Biologic | Evidence Level | Protocol | Healing Rate vs Standard Care |
|---|---|---|---|---|
| Diabetic Foot Ulcer (neuropathic) | dHACM (EpiFix) or cryopreserved allograft (Grafix) | Level I — multiple RCTs | Weekly application × 4–12 weeks; offloading essential | EpiFix 92% at 6 weeks vs 8% standard (Zelen 2013 RCT) |
| Venous Leg Ulcer | Apligraf or dHACM | Level I (Apligraf FDA-approved) | Every 1–2 weeks × 6–12 weeks; compression mandatory | Apligraf 63% closure vs 49% standard at 6 months |
| Pressure Ulcer (Stage III–IV) | dHACM or collagen matrix | Level II–III | Weekly ± surgery for debridement; pressure relief | Reduced healing time vs standard wound care |
| Post-Surgical Wound Dehiscence | dHACM or amniotic fluid concentrate | Level III | Q1–2 week application; protect epithelializing edges | Accelerates secondary intention healing |
| Ischemic Ulcer (after revascularization) | dHACM or collagen matrix post-revasculatization | Level II | After adequate perfusion confirmed (TcPO₂ >40 mmHg) | Enhances healing response once perfusion is restored |
Quick answer: Wound Care Biologics Placental Allograft Michigan Podiatrist is a common foot/ankle topic that affects many patients. The 2026 evidence-based approach combines proper diagnosis, conservative-first treatment, and escalation only when needed. We treat this regularly at our Howell and Bloomfield Township practices. Call (810) 206-1402.
Foot pain isn't resolving?
Same-week appointments at Howell & Bloomfield Hills
Medically Reviewed | Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle, Michigan
Quick Answer:
Quick Answer: Wound care biologics are advanced tissue-derived products that supplement the wound healing environment to accelerate closure of chronic non-healing wounds — particularly diabetic foot ulcers, venous stasis ulcers, and pressure injuries. Products include: placental allograft (amniotic membrane / chorion membrane — contains growth factors, extracellular matrix proteins, and anti-inflammatory cytokines), acellular dermal matrices (collagen scaffolds derived from porcine or bovine dermis), and autologous platelet-rich plasma (PRP) applied topically. Indications: wounds that have failed standard care at 4 weeks (cleansing, debridement, offloading) — non-progressing diabetic foot ulcers are the primary indication. Application: applied to the debrided wound bed after standard preparation. Coverage: Medicare covers placental allograft for qualifying diabetic foot ulcers — prior authorization required. Must be combined with adequate offloading (total contact cast or CAM boot) for success.
Watch: Diabetic Foot Ulcer Treatment & Early Stages [Diabetic Neuropathy] — MichiganFootDoctors YouTube
Advanced wound care biologics — placental allograft, amniotic membrane, and acellular dermal matrices — represent the current frontier in treating chronic non-healing wounds that fail standard wound care protocols. For patients with diabetic foot ulcers, venous stasis ulcers, or pressure injuries that have not closed after 4 weeks of appropriate standard care, biologics provide a concentrated delivery of growth factors, extracellular matrix scaffolding, and anti-inflammatory cytokines that restore the biologically permissive wound environment. At Balance Foot & Ankle PLLC, Dr. Tom Biernacki integrates advanced wound care biologics into a comprehensive diabetic and chronic wound management protocol.
Types of Wound Care Biologics
Placental allograft (amniotic membrane/chorion): Derived from donated human placental tissue, placental allograft contains a rich cocktail of growth factors (EGF, FGF, VEGF, TGF-β), extracellular matrix proteins (collagen, fibronectin, laminin), and anti-inflammatory cytokines. Available in dehydrated (DHACM), cryopreserved, and particulate forms. Applied directly to the debrided wound bed, biologic products deliver the molecular signals that chronic wounds lack — particularly important in diabetic wounds where hyperglycemia impairs normal growth factor signaling. Acellular dermal matrix (ADM): Collagen scaffolds derived from porcine or bovine dermis, providing structural support for new tissue ingrowth. Products: Integra, MatriStem, OASIS. Applied to the wound bed as a template for dermal regeneration. Autologous PRP: Patient’s own platelet-rich plasma — centrifuged from a blood draw — applied topically or injected into wound margins. Contains autologous growth factors without allograft tissue. Synthetic growth factors: PDGF (Becaplermin/Regranex) — the only FDA-approved recombinant growth factor gel for diabetic foot ulcers.
Indications and Medicare Coverage
Wound care biologics are indicated for chronic wounds failing standard care at 4 weeks — the Medicare benchmark is wounds that have not progressed after 4 weeks of standard care (cleansing, moist dressing, debridement, and offloading). The primary indication is diabetic foot ulcers (DFUs) that have been properly debrided, adequately vascularized (ankle-brachial index >0.8 or toe pressure >40mmHg), and appropriately offloaded but remain non-healing. Medicare coverage: CMS covers placental allograft products for qualifying diabetic foot ulcers — prior authorization is required, and documentation of adequate standard care failure at 4 weeks is mandatory. Products covered include EPIFIX, MiMedx, Amnioband, and others — specific coverage depends on MAC local coverage determinations. Dr. Biernacki’s wound care team coordinates prior authorization for eligible patients.
The Role of Offloading
Wound care biologics provide the biological stimulus for healing — but offloading is the non-negotiable foundation without which no biologic can succeed in a plantar diabetic foot ulcer. Total contact casting (TCC) or an irremovable CAM boot provide the consistent offloading that plantar forefoot ulcers require. Clinical trials consistently show that patients in TCC achieve healing rates of 65-85% vs. 30-40% in CAM boots — because the TCC is irremovable and provides continuous offloading. Biologics applied to a wound that continues to bear weight will not heal. The combination of appropriate offloading + biologic application + serial debridement produces the highest closure rates for chronic diabetic foot ulcers.
Dr. Tom's Product Recommendations
O’Keeffe’s Healthy Feet Foot Cream
⭐ Highly Rated | Foundation Wellness Partner | 30% Commission
Concentrated therapeutic foot cream for diabetic foot skin care — daily moisturization prevents the dry cracked skin that can progress to fissures and wound entry points in diabetic patients.
Dr. Tom says: “My podiatrist recommended O’Keeffe’s for my diabetic foot care and daily use significantly reduced the dryness and cracking that was putting me at wound risk.”
Diabetic foot skin care, wound prevention, dry cracked heel moisturizing cream
Apply to dry skin only — avoid applying to open wounds or between toes to prevent interdigital maceration
Disclosure: We earn a commission at no extra cost to you.
Ossur Rebound Air Walker Offloading Boot
⭐ Highly Rated | Foundation Wellness Partner | 30% Commission
Pneumatic CAM walker for diabetic wound offloading — used as part of the offloading protocol during biologic wound care treatment to protect healing diabetic foot ulcers.
Dr. Tom says: “My podiatrist prescribed an offloading boot for my diabetic foot ulcer treatment and the pressure redistribution allowed my wound to heal while I continued walking.”
Diabetic foot ulcer offloading, wound care CAM boot, forefoot pressure redistribution
Medical prescription device — CAM boot offloading is less effective than total contact casting; discuss optimal offloading with Dr. Biernacki
Disclosure: We earn a commission at no extra cost to you.
✅ Pros / Benefits
- Placental allograft provides concentrated growth factors that chronically stalled wounds lack
- Medicare covers biologics for qualifying diabetic foot ulcers after standard care failure at 4 weeks
- Combined biologic application + total contact casting produces 65-85% closure rates
- Serial debridement prior to biologic application ensures the product contacts viable wound tissue
❌ Cons / Risks
- Biologics are ineffective without adequate offloading — the wound healing environment must be controlled
- Prior authorization is required for Medicare coverage — documentation of standard care failure mandatory
- Adequate vascular supply is a prerequisite — ischemic wounds require revascularization before biologics
Dr. Tom Biernacki’s Recommendation
Wound care biologics work when the biologic hierarchy is respected: vascularity first, offloading always, debridement at every visit, and then biologics fill the gap for wounds that won’t progress with standard care. The mistake I see is biologics applied to wounds that aren’t adequately offloaded — no amount of growth factor will heal a wound that the patient is walking on unprotected. When the foundation is correct — total contact casting, serial debridement, adequate blood flow — placental allograft and amniotic membrane products produce remarkable results in wounds that had been stalled for months.
— Dr. Tom Biernacki, DPM | Board-Certified Podiatric Surgeon | Balance Foot & Ankle
Frequently Asked Questions
What is placental allograft for wound care?
Placental allograft is an advanced wound care biologic derived from donated human placental tissue — specifically the amniotic membrane and chorion, which are the inner layers of the placenta. These tissues are rich in growth factors (proteins that stimulate cell growth and tissue repair), extracellular matrix components (the structural scaffolding of tissue), and anti-inflammatory cytokines that regulate the wound healing environment. In chronic non-healing wounds, the normal wound healing cascade has stalled — often from impaired growth factor signaling (common in diabetic wounds). Applying placental allograft restores the biological signals needed for cell migration, angiogenesis (new blood vessel formation), and collagen deposition.
Does Medicare cover wound care biologics for diabetic foot ulcers?
Yes — Medicare covers certain wound care biologic products for qualifying diabetic foot ulcers under specific coverage criteria. The wound must: be a chronic diabetic foot ulcer, have failed to progress with standard wound care (cleaning, debridement, moist dressing, and offloading) for 4 weeks, have adequate vascular supply, and have no active infection. Prior authorization is required — our wound care team submits documentation of standard care failure and wound characteristics. Specific product coverage varies by region and Medicare Administrative Contractor (MAC) — not all biologic products are covered equally.
How do wound care biologics work?
Wound care biologics work by delivering the biological molecules that chronic wound environments lack. Normal acute wounds heal through a predictable sequence: inflammation, proliferation, and remodeling — driven by growth factors, cytokines, and extracellular matrix proteins. In chronic diabetic foot ulcers, this cascade stalls due to hyperglycemia-impaired growth factor signaling, oxidative stress, bacterial biofilm, and persistent inflammation. Biologics (placental allograft, growth factors, collagen matrices) provide: growth factors to stimulate cell proliferation and migration, anti-inflammatory cytokines to reduce chronic inflammation, and structural scaffolding for new tissue formation.
What happens if a diabetic foot ulcer doesn’t heal?
Diabetic foot ulcers that fail to heal are at risk for progressive infection — cellulitis, osteomyelitis, and necrotizing fasciitis. These infections can be life-threatening and are the leading cause of non-traumatic lower extremity amputation in the United States. The standard guideline: a diabetic foot ulcer that has not reduced in area by 50% after 4 weeks of standard care should trigger escalation to advanced therapies (biologics, negative pressure wound therapy, offloading reassessment) and vascular evaluation. Early aggressive management of non-healing wounds prevents the infectious complications that lead to amputation.
Michigan Foot Pain? See Dr. Biernacki In Person
4.9★ rated | 1,123 Reviews | 3,000+ Surgeries
Same-week appointments · Howell & Bloomfield Hills
📞 (810) 206-1402 Book Online →Frequently Asked Questions
When should I see a podiatrist?
If symptoms persist past 2 weeks, affect your normal activity, or are accompanied by red-flag symptoms (warmth, redness, swelling, inability to bear weight).
What does treatment cost?
Most diagnostic visits and conservative treatments are covered by Medicare and major insurers. Out-of-pocket costs vary by your specific plan.
How quickly can I get an appointment?
Most non-urgent cases see us within 5 business days. Urgent cases (sudden pain, possible fracture) typically same or next business day.
What is Wound care?
Wound care is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.
Symptoms and warning signs
Common signs of wound care include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.
Conservative treatment options
Most cases of wound care respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.
When is surgery considered?
Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.
Recovery timeline and prevention
Recovery from wound care varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.
Ready to feel better?
Same-week appointments available in Howell and Bloomfield Hills, Michigan.
Book Your Visit
Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.
- Plantar Fasciitis: Diagnosis and Conservative Management (PubMed)
- Plantar Fasciitis (APMA)
- Diagnosis and Treatment of Plantar Fasciitis (PubMed / AAFP)
- Heel Pain (APMA)